# Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane

> **NCT01773460** · PHASE3 · TERMINATED · sponsor: **GBG Forschungs GmbH** · enrollment: 3 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** Everolimus
- **DRUG:** Everolimus-placebo

## Key facts

- **NCT ID:** NCT01773460
- **Lead sponsor:** GBG Forschungs GmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-07
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Study was stopped terminated early due to low recruitment.
- **Last updated:** 2016-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01773460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01773460, "Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01773460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*